Scandinavian Biopharma services

Our development is mainly focused on developing the first vaccine in the world against Enterotoxigenic Escherichia Coli (ETEC) induced diarrhoea. Our vision is to develop an ETEC vaccine with the potential of saving hundreds of thousand lives and preventing considerable physical suffering and malnutrition due to repeated bouts of diarrhea in children below five years of age in low- and middle-income countries. Furthermore, the vaccine has the potential to prevent the loss of millions of well-deserved holiday trips and negative long-term gastrointestinal syndromes due to travellers’diarrhoea.